|
1
|
Cancian L, Hansen A and Boshoff C:
Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated
herpesvirus-induced cell reprogramming. Trends Cell Biol.
23:421–432. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang X, Zhang Z, Liu T, Li X, Zhang Q,
Wang L, Lu X, Lin R and Wen H: Analysis of infection rate of human
herpes virus 8 in blood donors in Xinjiang Autonomous Region. Chin
J Infect Dis. 27:502–504. 2009.(In Chinese).
|
|
3
|
Lester SN and Li K: Toll-like receptors in
antiviral innate immunity. J Mol Biol. 426:1246–1264. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laresche C, Fournier E, Dupond AS,
Woronoff AS, Drobacheff-Thiebaut C, Humbert P and Aubin F: Kaposi's
sarcoma: A population-based cancer registry descriptive study of 57
consecutive cases diagnosed between 1977 and 2009. Int J Dermatol.
53:e549–e554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alcendor DJ: KSHV Down-regulates
Tropoelastin in Both an in-vitro and in-vivo Kaposi's Sarcoma
Model. J Oncobiomarkers. 2:1–7. 2015.PubMed/NCBI
|
|
7
|
Machado PR, Farias KJ, Pereira MG, Freitas
PP and Fonseca BA: Human herpesvirus 8 (HHV-8) detected by nested
polymerase chain reaction (PCR) in HIV patients with or without
Kaposi's sarcoma. An analytic cross-sectional study. Sao Paulo Med
J. 134:187–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fernandes F, Eloy C, Carimo A, Pinto P,
Graves S, Simões J, Carrilho C and Lopes JM: Simultaneous
presentation of Kaposi sarcoma and HHV8-associated large B-cell
lymphoma in the same lymph node: A rare diagnosis in an
HIV-negative patient. Am J Case Rep. 14:263–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boivin G, Côté S, Cloutier N, Abed Y,
Maguigad M and Routy JP: Quantification of human herpesvirus 8 by
real-time PCR in blood fractions of AIDS patients with Kaposi's
sarcoma and multicentric Castleman's disease. J Med Virol.
68:399–403. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang HW, Trotter MW, Lagos D, Bourboulia
D, Henderson S, Mäkinen T, Elliman S, Flanagan AM, Alitalo K and
Boshoff C: Kaposi sarcoma herpesvirus-induced cellular
reprogramming contributes to the lymphatic endothelial gene
expression in Kaposi sarcoma. Nat Genet. 36:687–693. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bauer AK, Dixon D, DeGraff LM, Cho HY,
Walker CR, Malkinson AM and Kleeberger SR: Toll-like receptor 4 in
butylated hydroxytoluene-induced mouse pulmonary inflammation and
tumorigenesis. J Natl Cancer Inst. 97:1778–1781. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang K, Zhou B, Wang Y, Rao L and Zhang
L: The TLR4 gene polymorphisms and susceptibility to cancer: A
systematic review and meta-analysis. Eur J Cancer. 49:946–954.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll protein
signals activation of adaptive immunity. Nature. 388:394–397. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Yang L, Tan XH, Li F, Qin J, Guo S,
Pu X and Xie J: Detection of HHV-8 DNA in Serum of 29 Xinjiang
Classic Kaposi Sarcoma by Nested PCR. Chin J Dermatovenereol.
19:329–220. 2005.(In Chinese).
|
|
15
|
Lagos D, Vart RJ, Gratrix F, Westrop SJ,
Emuss V, Wong PP, Robey R, Imami N, Bower M, Gotch F and Boshoff C:
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma
herpesvirus. Cell Host Microbe. 4:470–483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou L, Shang H, Wang Y, Li G, Ding H,
Zhang X, Dai D and Shi W: The expression of TLR4 on peripheral
blood monocyte and TNF-α concentration of plasma in Chinese
HIV/AIDS patients. Chin J Microbiol Immunol. 27:1016–1019. 2007.(In
Chinese).
|
|
17
|
Lester RT, Yao XD, Ball TB, McKinnon LR,
Kaul R, Wachihi C, Jaoko W, Plummer FA and Rosenthal KL: Toll-like
receptor expression and responsiveness are increased in viraemic
HIV-1 infection. AIDS. 22:685–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bosinger SE, Hosiawa KA, Cameron MJ,
Persad D, Ran L, Xu L, Boulassel MR, Parenteau M, Fournier J, Rud
EW and Kelvin DJ: Gene expression profiling of host response in
models of acute HIV infection. J Immunol. 173:6858–6863. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Speicher DJ, Sehu MM, Johnson NW and Shaw
DR: Successful treatment of an HIV-positive patient with unmasking
Kaposi's sarcoma immune reconstitution inflammatory syndrome. J
Clin Virol. 57:282–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tamburro KM, Yang D, Poisson J, Fedoriw Y,
Roy D, Lucas A, Sin SH, Malouf N, Moylan V, Damania B, et al:
Vironome of Kaposi sarcoma associated herpesvirus-inflammatory
cytokine syndrome in an AIDS patient reveals co-infection of human
herpesvirus 8 and human herpesvirus 6A. Virology. 433:220–225.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maimaitiaili W, Pan K, Lu X, Sun X,
Yibaguli A, Yang K, Zuohela T, Adili K and Zhang Y: Clinical,
pathological and prognosis analyses of AIDS patients with Kaposi
sarcoma. Chin J Infect Dis. 30:368–370. 2012.(In Chinese).
|
|
22
|
Rea K, Sensi M, Anichini A, Canevari S and
Tomassetti A: EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK
phosphorylated on serine 732 contributes to microtubule
depolymerization and mitosis in tumor cells. Cell Death Dis.
4:e8152013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buscà R, Christen R, Lovern M, Clifford
AM, Yue JX, Goss GG, Pouysségur J and Lenormand P: ERK1 and ERK2
present functional redundancy in tetrapods despite higher evolution
rate of ERK1. BMC Evol Biol. 15:1792015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh A, Ruan Y, Tippett T and Narendran
A: Targeted inhibition of MEK1 by cobimetinib leads to
differentiation and apoptosis in neuroblastoma cells. J Exp Clin
Cancer Res. 34:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tamminen JA, Yin M, Rönty M, Sutinen E,
Pasternack A, Ritvos O, Myllärniemi M and Koli K: Overexpression of
activin-A and -B in malignant mesothelioma-attenuated Smad3
signaling responses and ERK activation promote cell migration and
invasive growth. Exp Cell Res. 332:102–115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park HS, You GE, Yang KH, Kim JY, An S,
Song JY, Lee SJ, Lim YK and Nam SY: Role of AKT and ERK pathways in
controlling sensitivity to ionizing radiation and adaptive response
induced by low-dose radiation in human immune cells. Eur J Cell
Biol. 9:653–660. 2015. View Article : Google Scholar
|
|
27
|
Nguyen MP, Lee D, Lee SH, Lee HE, Lee HY
and Lee YM: Deguelin inhibits vasculogenic function of endothelial
progenitor cells in tumor progression and metastasis via
suppression of focal adhesion. Oncotarget. 6:16588–16600. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shostak K and Chariot A: EGFR and NF-κB:
Partners in cancer. Trends Mol Med. 21:385–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cannon M, Philpott NJ and Cesarman E: The
Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
has broad signaling effects in primary effusion lymphoma cells. J
Virol. 77:57–67. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pati S, Cavrois M, Guo HG, Foulke JS Jr,
Kim J, Feldman RA and Reitz M: Activation of NF-kappaB by the human
herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine
model of Kaposi's sarcoma pathogenesis. J Virol. 75:8660–8673.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gregory SM, West JA, Dillon PJ, Hilscher
C, Dittmer DP and Damania B: Toll-like receptor signaling controls
reactivation of KSHV from latency. Proc Natl Acad Sci USA.
106:11725–11730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hävemeier A, Gramolelli S, Pietrek M,
Jochmann R, Stürzl M and Schulz TF: Activation of NF-κB by the
Kaposi's sarcoma-associated herpesvirus K15 protein involves
recruitment of the NF-κB -inducing kinase, IκB kinases, and
phosphorylation of p65. J Virol. 88:13161–13172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jacobs SR, Gregory SM, West JA, Wollish
AC, Bennett CL, Blackbourn DJ, Heise MT and Damania B: The viral
interferon regulatory factors of kaposi's sarcoma-associated
herpesvirus differ in their inhibition of interferon activation
mediated by toll-like receptor 3. J Virol. 87:798–806. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meyer F, Ehlers E, Steadman A, Waterbury
T, Cao M and Zhang L: TLR-TRIF pathway enhances the expression of
KSHV replication and transcription activator. J Biol Chem.
288:20435–20442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ahmad H, Gubbels R, Ehlers E, Meyer F,
Waterbury T, Lin R and Zhang L: Kaposi sarcoma-associated
herpesvirus degrades cellular Toll-interleukin-1 receptor
domain-containing adaptor-inducing beta-interferon (TRIF). J Biol
Chem. 286:7865–7872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo Y, Li Y, Wei X, Feng Z and Yang S:
Expression of TLR2 and TLR4 in primary liver cancer. Chin J
Pathophysiol. 24:1912–1915. 2008.(In Chinese).
|
